peptid
inhibitor
coronaviru
current
caus
worldwid
pandem
design
simul
inhibitor
mostli
form
two
sequenti
selfsupport
bundl
extract
proteas
domain
pd
angiotensinconvert
enzym
bind
receptor
bind
domain
molecular
dynam
simul
reveal
peptid
maintain
secondari
structur
provid
highli
specif
stabl
bind
block
provid
multival
bind
receptor
mani
peptid
could
attach
surfac
nanoparticl
carrier
propos
peptid
inhibitor
could
provid
simpl
effici
therapeut
diseas
ever
acut
respiratori
syndrom
coronaviru
previous
known
novel
coronaviru
caus
pandem
coronaviru
diseas
share
genom
ident
sarscov
emerg
highli
contagi
human
rapidli
caus
unpreced
pandem
larg
number
fatal
worldwid
virion
nm
diamet
contain
four
structur
protein
known
spike
e
envelop
membran
n
nucleocapsid
protein
protein
imag
atom
level
use
cryoelectron
microscopi
respons
host
attach
fusion
viral
hostcel
membran
process
trigger
subunit
protein
bind
hostcel
receptor
engag
hostcel
receptor
receptorbind
domain
rbd
undergo
transient
hingelik
conform
motion
receptoraccess
receptorinaccess
state
angiotensinconvert
enzym
host
cellular
receptor
higher
affin
sarscov
recognit
rbd
proteas
domain
pd
mainli
engag
helix
minor
contribut
helix
linker
sheet
addit
hectic
search
vaccin
fast
ongo
search
therapeut
act
depend
activ
therapi
divid
sever
main
categori
prevent
viral
rna
synthesi
replic
block
viru
bind
human
cell
receptor
restor
host
innat
immun
block
host
specif
receptor
enzym
despit
mani
experiment
comput
studi
current
explor
categori
date
confirm
effect
treatment
specif
avail
comput
approach
use
search
potenti
therapeut
proteas
categori
analog
screen
potenti
drug
protein
categori
provid
small
molecular
compound
high
bind
affin
unfortun
compound
attach
bind
interfac
complex
hesperidin
predict
lie
surfac
rbd
cover
whole
interfac
earli
attempt
sarscov
block
short
peptid
inhibitor
studi
amino
acid
mutat
implement
protein
sarscov
howev
propos
peptid
short
residu
maintain
secondari
structur
unabl
block
whole
sarscov
bind
surfac
broadspectrum
antivir
nanoparticl
cyclodextrin
design
simul
implement
block
virus
categori
inhibitor
applic
unknown
protein
rigid
peptid
specif
multival
bind
domain
conform
match
rbd
could
promis
therapeut
overal
protein
therapi
show
high
specif
small
interfer
biolog
process
good
toler
human
organ
faster
fda
approv
time
work
design
simul
sever
peptid
inhibitor
includ
compon
virusbind
domain
base
recent
releas
crystal
structur
pdb
code
inhibitor
rel
low
molecular
weight
structur
stabl
conform
match
protein
highli
specif
studi
could
provid
potenti
guidanc
antigen
recognit
structurebas
design
antibodi
high
affin
propos
small
peptid
could
use
inhal
therapeut
topic
lung
deliveri
provid
effici
way
combat
prepar
inhibitor
crystal
structur
rbd
pdb
first
analyz
interact
amino
acid
rbd
interfac
total
residu
interact
rbd
residu
q
k
h
e
e
q
one
residu
residu
come
residu
k
g
r
come
linker
therefor
amino
acid
label
critic
amino
acid
critic
bind
compon
interact
residu
pick
inhibitor
helix
alon
particular
residu
shown
figur
select
realiz
alon
might
even
stabl
next
pick
inhibitor
helic
residu
residu
residu
shown
orang
figur
select
includ
interact
residu
crystal
structur
two
close
join
one
side
figur
stabil
connect
two
helic
red
residu
orang
shown
figur
residu
leu
leu
link
togeth
side
chain
bond
shown
figur
also
design
inhibitor
closer
protein
whose
part
connect
peptid
bond
contain
residu
initi
bind
rbd
crystal
structur
figur
detail
figur
show
inhibitor
residu
orang
includ
two
random
coil
residu
wherea
residu
red
includ
two
anoth
random
coil
residu
two
sequenc
join
togeth
peptid
bond
residu
two
piec
random
coil
move
close
final
figur
detail
figur
show
inhibitor
two
sequenc
includ
residu
red
residu
orang
select
extra
peptid
bond
made
residu
residu
adjust
posit
correspond
sequenc
sequenc
inhibitor
shown
tabl
examin
potenti
inhibitor
bind
rbd
prepar
system
initi
posit
known
crystal
structur
pdb
simul
physiolog
solut
method
shown
figur
control
pd
residu
rbd
also
simul
figur
bind
conform
figur
ns
long
simul
show
helic
structur
inhibitor
deform
left
end
unfold
although
still
bind
rbd
figur
ns
long
simul
reveal
inhibitor
bind
stabl
way
rbd
without
lose
structur
due
differ
linkag
among
critic
bind
compon
overal
conform
inhibitor
vari
specif
helix
mostli
contribut
complementari
sequenc
conform
match
rbd
maintain
inhibitor
differ
degre
bend
structur
inhibitor
also
preserv
overal
critic
bind
compon
inhibitor
bind
rbd
manner
similar
crystal
structur
simul
stabl
conform
inhibitor
correspond
energi
minima
fold
would
drive
fold
process
toward
stabl
direct
energi
quantifi
bind
inhibitor
rbd
calcul
rmsd
critic
amino
acid
inhibitor
whole
inhibitor
figur
show
averag
rmsd
end
simul
see
also
figur
inhibitor
larger
rmsd
critic
amino
acid
compar
control
largest
fluctuat
critic
amino
acid
overal
rmsd
figur
b
attribut
unfold
shown
figur
highli
promis
inhibitor
rmsd
critic
amino
acid
overal
rmsd
similar
control
lowest
inhibitor
rmsd
critic
amino
acid
overal
rmsd
higher
control
inhibitor
howev
figur
show
inhibitor
smooth
overal
rmsd
later
time
may
due
poor
adapt
ad
connect
earli
time
inhibitor
show
slightli
bigger
fluctuat
overal
rmsd
steadi
rmsd
figur
critic
amino
acid
later
time
indic
fluctuat
shown
overal
structur
come
nonessenti
connect
part
interact
energi
van
der
waal
vdw
electrostat
compon
calcul
namd
energi
plugin
total
energi
shown
figur
g
figur
detail
residu
contribut
interact
energi
inhibitor
select
cutoff
select
updat
everi
frame
inhibitor
show
interact
energi
similar
control
inhibitor
slightli
stronger
bind
control
howev
inhibitor
show
interact
energi
slightli
lower
control
larger
interact
energi
inhibitor
might
due
nonspecif
interact
caus
deform
helix
lower
interact
energi
inhibitor
could
attribut
total
number
residu
less
inhibitor
summari
use
classic
molecular
dynam
simul
shown
peptid
inhibitor
extract
provid
highli
promis
trail
block
singl
helix
use
inhibitor
less
stabl
wherea
helic
use
inhibitor
support
retain
bent
shape
provid
conform
match
rbd
full
cover
rbd
surfac
precis
conform
match
design
peptid
viru
provid
room
improv
bind
affin
consid
futur
inhibitor
design
protocol
suitabl
inhibitor
select
bind
lower
rmsd
critic
amino
acid
rel
high
bind
energi
bind
affin
could
enhanc
multival
bind
multipl
peptid
attach
surfac
nanoparticl
dendrim
cluster
analog
nanoparticlebas
inhibitor
could
attach
helix
sulphon
ligand
mimick
heparan
sulfat
attach
posit
charg
residu
bottom
rbd
inhibitor
could
use
inhal
therapeut
prevent
viru
activ
lung
inhibitor
rbd
viru
simul
namd
protein
forc
field
particl
mesh
ewald
pme
method
use
evalu
longrang
coulomb
interact
time
step
set
fs
simul
perform
npt
ensembl
p
bar
k
use
langevin
dynam
damp
constant
ps
step
minim
ion
water
molecul
equilibr
ns
around
protein
restrain
use
harmon
forc
spring
constant
kcal
mol
last
frame
restrain
equilibr
use
start
simul
free
inhibitor
partial
constrain
pd
two
residu
bottom
simul
last
ns
due
differ
atom
number
differ
system
differ
comput
power
use
calcul
rmsd
timedepend
rmsd
critic
amino
acid
whole
inhibitor
figur
calcul
n
number
atom
whose
posit
compar
j
posit
atom
time
j
initi
coordin
select
coordin
contain
atom
inhibitor
critic
amino
acid
exclud
hydrogen
timedepend
rmsd
averag
last
ns
simul
time
correspond
last
frame
trajectori
shown
figur
standard
deviat
shown
error
bar
calcul
bind
energi
interact
residu
inhibitor
rbd
first
select
cutoff
distanc
electrostat
vdw
energi
contribut
interact
residu
calcul
namd
energi
plugin
electrostat
contribut
given
j
distanc
two
charg
q
q
j
dielectr
constant
solvent
set
increas
effici
simul
pairwis
interact
calcul
perform
beyond
cutoff
distanc
longrang
electrostat
interact
calcul
pme
method
lennardjon
lj
potenti
energi
use
describ
vdw
interact
close
distanc
atom
repuls
ij
maximum
stabil
energi
ith
jth
atom
ij
distanc
ith
jth
atom
minimum
potenti
r
ij
actual
distanc
two
atom
lj
paramet
differ
atom
type
calcul
use
mix
rule
ij
ii
jj
ij
ii
jj
berthelot
rule
time
evolut
interact
energi
shown
figur
timeaverag
interact
energi
last
ns
frame
shown
figur
standard
deviat
shown
error
bar
support
inform
avail
free
charg
http
sequenc
inhibitor
rmsd
critic
amino
acid
inhibitor
whole
inhibitor
interact
energi
contact
residu
inhibitor
pdf
